Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEBRA pioneered the first hand-held radio frequency tube sealer to create permanent sterile seals in blood tubing since its founding in 1976. It has been a worldwide leader providing reliable sealing solutions critical to maintaining sterility during blood collection and biopharmaceutical single-use manufacturing processes. The product portfolio includes benchtop and handheld RF sealers with patented SMART™ circuitry that automatically adjusts to different tubing sizes. After being sold to Haemonetics in 2009, the brand was reacquired by Vante/Machine Solutions Inc. in 2017 where it continues innovation. No clinical results apply as this is not a clinical-stage biotech/pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SEBRA BioPharma Solutions.